| Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013 | 5767 | 2013 |
| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 3817 | 2014 |
| A landscape of driver mutations in melanoma E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ... Cell 150 (2), 251-263, 2012 | 2931 | 2012 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2671 | 2015 |
| Highly recurrent TERT promoter mutations in human melanoma FW Huang, E Hodis, MJ Xu, GV Kryukov, L Chin, LA Garraway Science 339 (6122), 957-959, 2013 | 2107 | 2013 |
| Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing M Imielinski, AH Berger, PS Hammerman, B Hernandez, TJ Pugh, ... Cell 150 (6), 1107-1120, 2012 | 1980 | 2012 |
| The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma EM Van Allen, N Wagle, A Sucker, DJ Treacy, CM Johannessen, ... Cancer discovery 4 (1), 94-109, 2014 | 960 | 2014 |
| Melanoma genome sequencing reveals frequent PREX2 mutations MF Berger, E Hodis, TP Heffernan, YL Deribe, MS Lawrence, ... Nature 485 (7399), 502-506, 2012 | 878 | 2012 |
| Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network E Collisson, J Campbell, A Brooks, A Berger, W Lee, J Chmielecki, D Beer, ... Nature 511 (7511), 543-550, 2014 | 822 | 2014 |
| MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition N Wagle, EM Van Allen, DJ Treacy, DT Frederick, ZA Cooper, ... Cancer discovery 4 (1), 61-68, 2014 | 527 | 2014 |
| RNF43 is frequently mutated in colorectal and endometrial cancers M Giannakis, E Hodis, X Jasmine Mu, M Yamauchi, J Rosenbluh, ... Nature genetics 46 (12), 1264-1266, 2014 | 476 | 2014 |
| Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq D Kotliar, A Veres, MA Nagy, S Tabrizi, E Hodis, DA Melton, PC Sabeti Elife 8, e43803, 2019 | 306 | 2019 |
| Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib N Wagle, BC Grabiner, EM Van Allen, E Hodis, S Jacobus, JG Supko, ... Cancer discovery 4 (5), 546-553, 2014 | 296 | 2014 |
| The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 196 | 2016 |
| The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov. 2014; 4: 94–109. doi: 10.1158/2159-8290 EM Van Allen, N Wagle, A Sucker, DJ Treacy, CM Johannessen, ... CD-13-0617.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 110 | |
| Proteopedia- a scientific 'wiki' bridging the rift between three-dimensional structure and function of biomacromolecules E Hodis, J Prilusky, E Martz, I Silman, J Moult, JL Sussman Genome biology 9, 1-10, 2008 | 105 | 2008 |
| MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition. Cancer Discov. 2014; 4: 61–68. doi: 10.1158/2159-8290 N Wagle, EM Van Allen, DJ Treacy, DT Frederick, ZA Cooper, ... Oncogene 34, 5599-5606, 2015 | 99 | 2015 |
| Overlapping codes within protein-coding sequences S Itzkovitz, E Hodis, E Segal Genome research 20 (11), 1582-1589, 2010 | 98 | 2010 |
| Proteopedia: A status report on the collaborative, 3D web-encyclopedia of proteins and other biomolecules J Prilusky, E Hodis, D Canner, WA Decatur, K Oberholser, E Martz, ... Journal of structural biology 175 (2), 244-252, 2011 | 65 | 2011 |
| Dermatologic Cooperative Oncology Group of Germany (DeCOG) EM Van Allen, N Wagle, A Sucker, DJ Treacy, CM Johannessen, ... The genetic landscape of clinical resistance to RAF inhibition in metastatic …, 2014 | 61 | 2014 |
